BIOSIMILAR INFLIXIMAB (CT-P13) IS NOT INFERIOR TO ORIGINATOR INFLIXIMAB: EXPLORATIVE SUBGROUP-ANALYSES IN CROHN’S DISEASE AND ULCERATIVE COLITIS IN THE NOR-SWITCH EXTENSION TRIAL  

Kristin Kaasen Kaasen Jørgensen  1     Guro L Goll  2     Joe Sexton  2     Inge C Olsen  2     Nils Bolstad  3     Knut E.A. Lundin  4     Ingrid P Berset     Espen A Haavardsholm     Cato Mørk     Tore K Kvien     Jørgen Jahnsen    
1 Akershus University Hospital,Department of Gastroenterology,Lørenskog,Norway
2 Diakonhjemmet Hospital,Department of Rheumatology,Oslo,Norway
3 Oslo University Hospital, Radiumhospitalet,Oslo,Norway
4 Oslo Universi

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing